GILD
Gilead Sciences, Inc. · Healthcare · Drug Manufacturers - General
TECHSellZACKSHold
R500#465 today
$144.74
-1.87% today · -4.10% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- GILD −1.87% on the last session vs SPY +0.74%: −2.6 pts of stock-specific move.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Oct 29
After the close · in 25 days
EPS estimate
$2.15
$1.90 to $2.68 · 22 analysts
Revenue estimate
$7.8B
$7.5B to $8.0B
Track record
8/8 beats
last 8 reports · moved ±4.6% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2026 AMC | 2Q2026 | −$7.25 | −$6.75 | +$0.50 (+6.9%) beat | — | -2.6% -2.4 vs SPY | +0.6% | +0.4% |
| May 7, 2026 AMC | 1Q2026 | $1.91 | $2.03 | +$0.12 (+6.2%) beat | $7.0B | -2.0% -2.9 vs SPY | -3.0% | -1.5% |
| Feb 10, 2026 AMC | 4Q2025 | $1.81 | $1.86 | +$0.05 (+2.8%) beat | $7.9B | +5.8% +5.8 vs SPY | +1.1% | +3.7% |
| Oct 30, 2025 AMC | 3Q2025 | $2.14 | $2.47 | +$0.33 (+15.7%) beat | $7.8B | +1.1% +0.8 vs SPY | -2.0% | +4.2% |
| Aug 7, 2025 AMC | $1.96 | $2.01 | +$0.05 (+2.6%) beat | — | +8.3% +7.5 vs SPY | +4.5% | +7.9% | |
| Apr 24, 2025 AMC | $1.78 | $1.81 | +$0.03 (+1.7%) beat | — | -2.8% -3.5 vs SPY | -3.3% | -2.7% | |
| Feb 11, 2025 AMC | $1.70 | $1.90 | +$0.20 (+11.8%) beat | — | +7.5% +7.8 vs SPY | +5.8% | +12.0% | |
| Nov 6, 2024 AMC | $1.55 | $2.02 | +$0.47 (+30.3%) beat | — | +6.8% +6.0 vs SPY | +2.5% | +1.0% | |
| Aug 8, 2024 AMC | $1.60 | $2.01 | +$0.41 (+25.6%) beat | — | -2.5% -3.0 vs SPY | -0.9% | -1.6% | |
| Apr 25, 2024 AMC | −$1.52 | −$1.32 | +$0.20 (+13.2%) beat | — | +0.2% -0.7 vs SPY | +0.3% | +0.1% | |
| Feb 6, 2024 AMC | $1.76 | $1.72 | −$0.04 (−2.3%) miss | — | -4.2% -5.1 vs SPY | -1.9% | -5.4% | |
| Nov 7, 2023 AMC | $1.92 | $2.29 | +$0.37 (+19.3%) beat | — | -3.4% -3.4 vs SPY | -3.9% | -7.3% | |
| Aug 3, 2023 AMC | $1.64 | $1.34 | −$0.30 (−18.3%) miss | — | +4.2% +4.6 vs SPY | +2.5% | +5.9% | |
| Apr 27, 2023 AMC | $1.54 | $1.37 | −$0.17 (−11.0%) miss | — | -1.6% -2.5 vs SPY | -1.2% | -6.0% | |
| Feb 2, 2023 AMC | $1.51 | $1.67 | +$0.16 (+10.6%) beat | — | +3.8% +4.9 vs SPY | +4.0% | +5.1% | |
| Oct 27, 2022 AMC | $1.43 | $1.90 | +$0.47 (+32.9%) beat | — | +12.9% +10.5 vs SPY | +5.9% | +13.2% | |
| Aug 2, 2022 AMC | $1.52 | $1.58 | +$0.06 (+3.9%) beat | — | +4.6% +3.0 vs SPY | +2.2% | +4.1% | |
| Apr 28, 2022 AMC | $1.81 | $2.12 | +$0.31 (+17.1%) beat | — | -3.6% +0.1 vs SPY | 0.0% | -0.3% | |
| Feb 1, 2022 AMC | $1.59 | $0.69 | −$0.90 (−56.6%) miss | — | -3.9% -4.8 vs SPY | -4.3% | -7.0% | |
| Oct 28, 2021 AMC | $1.78 | $2.65 | +$0.87 (+48.9%) beat | — | -3.6% -3.9 vs SPY | -2.1% | -1.3% | |
| Jul 29, 2021 AMC | $1.75 | $1.87 | +$0.12 (+6.9%) beat | — | — | — | — | |
| Apr 29, 2021 AMC | $2.11 | $2.08 | −$0.03 (−1.4%) miss | — | — | — | — | |
| Feb 4, 2021 AMC | $2.15 | $2.19 | +$0.04 (+1.9%) beat | — | — | — | — | |
| Oct 28, 2020 AMC | $1.89 | $2.11 | +$0.22 (+11.6%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $2.15 (22) | $1.90 – $2.68 | -13% | +3.5% | ▲6 ▼14 | $7.8B | 0% |
| Next quarter · Dec 31, 2026 | $2.19 (20) | $1.92 – $3.13 | +18% | -2.5% | ▲3 ▼16 | $8.1B | +3% |
| Current year · Dec 31, 2026 | −$0.43 (27) | −$0.62 – −$0.02 | -105% | -46.0% | ▲2 ▼0 | $30.7B | +4% |
| Next year · Dec 31, 2027 | $9.89 (26) | $9.19 – $11.10 | +2420% | +2.2% | ▲19 ▼6 | $32.7B | +6% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.